Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03580629 · ClinicalTrials.gov registry record · NA

Pilot Study of the Liver Live Donor Champion Program

A NA study, sponsored by Johns Hopkins University.

Completed
Registry status
NA
Development phase
76
Enrollment target

NCT03580629: Completed NA study, sponsored by Johns Hopkins University.

NCT03580629 is a NA study that has completed, run by Johns Hopkins University. The registered enrollment target is 76 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT03580629, a NA study, has completed, sponsored by Johns Hopkins University.

COMPLETED
Registry status
NA
Development phase
76 participants
Enrollment target

Study Summary

In this pilot study, investigators plan to enroll liver transplant candidates and a "Live Donor Champion" for an abridged two- or three-month program that provides education and advocacy training in order to expand access to live donor liver transplantation. Investigators have created two versions of the same program and based on feedback from participants and staff, investigators aim to analyze the efficacy of the Liver Liver Donor Champion program on this patient population.

Primary Outcome

Live Donor Inquiries on behalf of candidates will be collected/identified through electronic medical system.

Interventions

  • BEHAVIORAL Liver Live Donor Champion Program

Trial Details

FieldValue
Enrollment Target 76 participants
Start Date 2018-09-18
Est. Completion 2025-11-29
Phase NA
Johns Hopkins University

1,448 total trials

What the finished NCT03580629 record still lists

NCT03580629 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 76 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).

The record links to 0 conditions, and to 1 intervention - of which Liver Live Donor Champion Program is the first listed.

NCT03580629 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03580629 about?

NCT03580629 is a clinical study titled "Pilot Study of the Liver Live Donor Champion Program". In this pilot study, investigators plan to enroll liver transplant candidates and a "Live Donor Champion" for an abridged two- or three-month program that provides education and advocacy training in order to expand access to live donor liver transplantation. Investigators have created two versions o...

What is the current status of trial NCT03580629?

This trial is currently completed. It is a NA study. The enrollment target is 76 participants. The study started on 2018-09-18. Estimated completion is 2025-11-29.

What interventions are being tested in trial NCT03580629?

The interventions under investigation include: Liver Live Donor Champion Program (BEHAVIORAL).

Who is sponsoring clinical trial NCT03580629?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03580629's enrollment target sits among peer trials

76 1062nd of 2000 higher than 932 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02615184 · 76 participants · Phase 2

    A Study to Check the Safety of Dexlansoprazole and Learn If it Can Heal Erosive Esophagitis (EE) and Keep it Healed in Children 2 to 11 Years Old

  • NCT02821741 · 76 participants · NA

    Effects of External Ear Stimulation on Pain Perception and Mood

  • NCT03019757 · 76 participants

    Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease

  • NCT03353584 · 76 participants · NA

    Effect of Virtual Reality Technology for Pain Management of Vaso-Occlusive Crisis in Patients With Sickle Cell Disease

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03580629, the US trial registry maintained by the National Library of Medicine. NCT03580629 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.